Probiotics in 2015 their scope and use

Journal of Clinical Gastroenterology

Volumn 49, Issue , 2015, Pages S2-S6

  Sanders, Mary Ellen ^a  

^a DAIRY AND FOOD CULTURE TECHNOLOGIES   (United States)

Author keywords

Dietary guidelines; Fda; Meta analysis; Probiotic; Regulatory; Safety; Strain specificity

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FERMENTED PRODUCT; GASTROINTESTINAL INFECTION; GASTROINTESTINAL MUCORMYCOSIS; GOVERNMENT REGULATION; HUMAN; MEDICAL RESEARCH; MUCORMYCOSIS; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; VULNERABLE POPULATION; HUMAN EXPERIMENT; LEGISLATION AND JURISPRUDENCE; UNITED STATES;

BIOMEDICAL RESEARCH; HUMAN EXPERIMENTATION; HUMANS; PROBIOTICS; UNITED STATES; VULNERABLE POPULATIONS;

EID: 84944212208     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000350     Document Type: Article

References (37)

1. Glanville J, King S, Guarner F, et al. A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union. Nutrition J. 2015;14:16.
2. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506-514.
3. Vandenplas Y, Huys G, Daube G. Probiotics: an update. J Pediatr (Rio J). 2015;91:6-21.
4. Shanahan F, Quigley EM. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. Gastroenterology. 2014;146:1554-1563.
5. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7:688-693.
6. EFSA Panel on Dietetic Products NaA. Scientific Opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006. EFSA J. 2010;8:1763.
7. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014;4:CD005496.
8. King S, Glanville J, Sanders ME, et al. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. Br J Nutr. 2014;112:41-54.
9. Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015;2:CD006895.
10. Guidance for Clinical Investigators, Sponsors, and IRBs Investigational New Drug Applications (INDs)-Determining Whether Human Research Studies Can Be Conducted Without an IND. Available at: http://www.fda.gov/downloads/Drugs/Guidances/UCM229175.pdf.
11. Sanders ME, Klaenhammer TR, Ouwehand AC, et al. Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics. Ann N Y Acad Sci. 2014;1309:1-18.
12. Li M, Wang M, Donovan SM. Early development of the gut microbiome and immune-mediated childhood disorders. Semin Reprod Med. 2014;32:74-86.
13. Cox LM, Blaser MJ. Antibiotics in early life and obesity. Nat Rev Endocrinol. 2015;11:182-190.
14. Dore J, Blottiere H. The influence of diet on the gut microbiota and its consequences for health. Curr Opin Biotechnol. 2015;32C:195-199.
15. Issa I, Moucari R. Probiotics for antibiotic-associated diarrhea: do we have a verdict? World J Gastroenterol. 2014;20:17788-17795.
16. Rodgers B, Kirley K, Mounsey A. PURLs: prescribing an antibiotic? Pair it with probiotics. J Fam Pract. 2013;62:148-150.
17. Pies̈cik-Lech M, Shamir R, Guarino A, et al. Review article: the management of acute gastroenteritis in children. Aliment Pharmacol Ther. 2013;37:289-303.
18. Hungin AP, Mulligan C, Pot B, et al. European Society for Primary Care Gastroenterology. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide. Aliment Pharmacol Ther. 2013;38:864-86.
19. Guarner F, Khan AG, Garisch J, et al. World Gastroenterology Organization. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol. 2012;46:468-481.
20. Turner D, Levine A, Escher JC, et al. European Crohn's and Colitis Organization; European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr. 2012;55:340-361.
21. Abe AM, Gregory PJ, Hein DJ, et al. Survey and systematic literature review of probiotics stocked in academic medical centers within the United States. Hosp Pharm. 2013;48:834-847.
22. Schultz M, Baranchi A, Thurston L, et al. Consumer demographics and expectations of probiotic therapy in New Zealand: results of a large telephone survey. N Z Med J. 2011;124:36-43.
23. Hickey Y, Corish C. Irish dietitians' opinions and use of probiotics in patients with Clostridium difficile-associated disease. J Clin Gastroenterol. 2011;45:568-569.
24. Williams MD, Ha CY, Ciorba MA. Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations. J Clin Gastroenterol. 2010;44:631-636.
25. Mozaffarian D, Hao T, Rimm EB, et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392-2404.
26. Wang H, Troy LM, Rogers GT, et al. Longitudinal association between dairy consumption and changes of body weight and waist circumference: the Framingham Heart Study. Int J Obes (Lond). 2014;38:299-305.
27. Sonestedt E, Wirfalt E, Wallstrom P, et al. Dairy products and its association with incidence of cardiovascular disease: the Malmo diet and cancer cohort. Eur J Epidemiol. 2011;26:609-618.
28. Dalmeijer GW, Struijk EA, van der Schouw YT, et al. Dairy intake and coronary heart disease or stroke-a populationbased cohort study. Int J Cardiol. 2013;167:925-929.
29. Sluijs I, Forouhi NG, Beulens JW, et al. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am J Clin Nutr. 2012;96:382-390.
30. Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One. 2012;7:e34938.
31. Pelucchi C, Chatenoud L, Turati F, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012;23:402-414.
32. Sanders ME, Lenoir-Wijnkoop I, Salminen S, et al. Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann N Y Acad Sci. 2014;1309:19-29.
33. Sanders ME, Akkermans LM, Haller D, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010;1:164-185.
34. Trois L, Cardoso EM, Miura E. Use of probiotics in HIVinfected children: a randomized double-blind controlled study. J Trop Pediatr. 2008;54:19-24.
35. Chitapanarux I, Chitapanarux T, Traisathit P, et al. Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol. 2010;5:31.
36. U. S. Food and Drug Administration. Solgar, INC. Issues Voluntary Class I Recall Of ABC Dophiluss Powder. 2014. Available at: http://www.fda.gov/Safety/Recalls/ucm423219.htm Accessed March 3, 2014.
37. Government of the District of Columbia, Department of Health. Fatal Gastrointestinal Mucormycosis in an Infant Following Ingestion of Contaminated Dietary Supplement. 2014. Available at: http://doh.dc.gov/release/fatal-gastrointestinalmucormycosisinfant-following-ingestion-contaminated-dietary. Accessed March 3, 2015.